GlaxoSmithKline Recalls Two Lots of Ventolin HFA Albuterol Sulfate Inhalers | Asthma and Allergy Foundation of America
Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today
Ventolin Inhaler GSK
GlaxoSmithKline Recalls Ventolin Inhalers - Drug Company Announces Nationwide Recall
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media
What are the different types of inhalers? - My Pharmacy
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die - Bloomberg
Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada
Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler ( GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
GSK's Relvar Ellipta comes out on top in real world study
Adherium wins US clearance for GSK inhaler users to connect to new platform
GSK opens £56m Ellipta inhaler plant in the UK
GSK breathes freely as Mylan launches Advair generic in UK
GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients | Fierce Pharma
FDA Committees Recommend Approval of Breo Ellipta for Adult Asthma, but not Adolescent | RT
GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice
Drugmaker GSK recalling nearly 600,000 asthma inhalers in US
GSK's Arnuity and Incruse Ellipta Available in US for Asthma and COPD Patients | RT
Asthma Inhaler And Spacer Galaxy S7 Case by Lewis Houghton/science Photo Library - Pixels
Respiratory Inhaler Devices Market 2022 Global Competition
